Michael Kaufman
Overview
Michael Kaufman received an average of $1M in total compensation, including $357K in salary, at Mersana Therapeutics from 2018 to 2021.
Source: SEC filings on April 29, 2022 and April 27, 2021.
Related executives
We found 11 more executives who work or worked at Mersana Therapeutics.
Anna Protopapas
Mersana Therapeutics
Chief Executive Officer
Martin Huber
Mersana Therapeutics
Chief Executive Officer
Arvin Yang
Mersana Therapeutics
Chief Medical Officer
Brian DeSchuytner
Mersana Therapeutics
Chief Financial Officer
Timothy Lowinger
Mersana Therapeutics
Senior Vice President, Chief Science and Technology Officer
Alejandra Carvajal
Mersana Therapeutics
Chief Legal Officer
Mohan Bala
Mersana Therapeutics
Senior Vice President, Chief Development Officer
Tushar Misra
Mersana Therapeutics
Senior Vice President, Chief Manufacturing Officer
News
Mersana Therapeutics CEO Anna Protopapas' 2021 pay jumps 226% to $8.3M
April 29, 2022
Mersana Therapeutics Chief Medical Officer Arvin Yang receives $4.5M in 2020
April 27, 2021
Mersana Therapeutics CEO Anna Protopapas' 2019 pay falls 33% to $1.7M
April 20, 2020
Mersana Therapeutics CEO Anna Protopapas' 2018 pay jumps 184% to $2.6M
April 23, 2019